Background: The appropriate use of narcotics for postoperative pain control is controversial because of potential medication-induced complications. The authors sought to determine the effects of narcotics in the pediatric population following cranial vault remodeling operations.
Methods: A retrospective review was performed on 160 consecutive patients who underwent cranial vault remodeling for craniosynostosis.
Results: There was a statistically significant difference in total morphine equivalents in the group that experienced no emesis and those with at least one episode of emesis (0.97 morphine equivalents/kg versus 1.44 morphine equivalents/kg; p = 0.05). There was a statistically significant difference in hospital morphine equivalents in the group with documented respiratory events (average, 2.3 morphine equivalents/kg versus 1.3 morphine equivalents/kg in the nonevent group; p = 0.006). The patients who received dexmedetomidine had a trend toward a decrease in hospital narcotic administration with equivalent pain control (1.2 morphine equivalents/kg versus 1.9 morphine equivalents/kg; p = 0.09). There was a statistically significant positive correlation between total morphine equivalents for the hospitalization and hospital stay ( r = 0.27, p = 0.001). The amount of morphine equivalents used in the first 24 hours was also found to be an independent predictor of a respiratory event ( p = 0.002 by multivariate logistic regression). Independent positive predictors of hospital stay were age ( p < 0.001), intensive care unit time ( p < 0.001), and total morphine equivalents for the hospitalization ( p = 0.001) by multivariate analysis with linear regression.
Conclusion: The authors' study demonstrates improvement in outcomes with decreased use of narcotics, which establishes that there is a need to further explore postsurgical recovery outcomes with multimodal pain control.
Clinical Question/level Of Evidence: Therapeutic, III.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PRS.0000000000009696 | DOI Listing |
Pediatr Surg Int
November 2022
Division of Pediatric General Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Pediatric opioid exposure increases short- and long-term adverse events (AE). The addition of intravenous acetaminophen (IVA) to pediatric pain regimes to may reduce opioids but is not well studied postoperatively. Our objective was to quantify the impact of IVA on postoperative pain, opioid use, and AEs in pediatric patients after major abdominal and thoracic surgery.
View Article and Find Full Text PDFPlast Reconstr Surg
December 2022
From TriHealth Plastic and Reconstructive Surgery; and the Department of Plastic Surgery, Medical College of Wisconsin.
Background: The appropriate use of narcotics for postoperative pain control is controversial because of potential medication-induced complications. The authors sought to determine the effects of narcotics in the pediatric population following cranial vault remodeling operations.
Methods: A retrospective review was performed on 160 consecutive patients who underwent cranial vault remodeling for craniosynostosis.
Int J Pediatr Otorhinolaryngol
October 2022
Department of Otolaryngology Head & Neck Surgery, University of Michigan, Ann Arbor, MI, USA.
J Neurosurg Pediatr
May 2021
Departments of1Neurosurgery and.
Objective: Selective dorsal rhizotomy (SDR) requires significant postoperative pain management, traditionally relying heavily on systemic opioids. Concern for short- and long-term effects of these agents has generated interest in reducing systemic opioid administration without sacrificing analgesia. Epidural analgesia has been applied in pediatric patients undergoing SDR; however, whether this reduces systemic opioid use has not been established.
View Article and Find Full Text PDFHosp Pediatr
May 2020
Pediatrics, Columbia University Irving Medical Center, Columbia University, New York, New York;
Background: Multimodal analgesia (MMA) may reduce opioid use after surgery for Chiari malformation type I. An MMA protocol was implemented after both posterior fossa decompression without dural opening (PFD) and posterior fossa decompression with duraplasty (PFDD).
Methods: Scheduled nonsteroidal antiinflammatory drugs (ketorolac or ibuprofen) and diazepam were alternated with acetaminophen, and as-needed oxycodone or intravenous morphine.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!